Pierre-Vladimir Ennezat Selected Research

benfluorex (S 780)

1/2017	Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
4/2015	Fatal dynamic mitral regurgitation as a presentation of benfluorex-Induced valvular heart toxicity.
2/2015	Benfluorex: An active toxin for the development of aortic valve stenosis.
2/2015	Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study.
1/2015	Operative finding of aortic cusp prolapse in benfluorex-induced aortic regurgitation.
1/2015	Calcifications in benfluorex-induced valve heart disease: a misknown association.
12/2014	Benfluorex-induced mitral stenosis: a misknown etiology.
12/2013	Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study.
12/2012	Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre-Vladimir Ennezat Research Topics

Disease

11	Heart Failure 01/2021 - 11/2002
7	Acute Coronary Syndrome 04/2019 - 05/2006
6	Mitral Valve Insufficiency (Mitral Regurgitation) 05/2018 - 08/2010
5	Hemorrhage 04/2019 - 10/2008
5	Heart Valve Diseases (Valvular Heart Disease) 01/2017 - 06/2013
5	Myocardial Infarction 01/2016 - 05/2006
4	Aortic Valve Stenosis (Aortic Stenosis) 10/2016 - 10/2008
3	Thrombosis (Thrombus) 04/2021 - 06/2007
3	Atrial Fibrillation 07/2015 - 05/2005
3	Aortic Valve Insufficiency (Aortic Regurgitation) 02/2015 - 12/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2018
2	Mitral Valve Stenosis (Mitral Stenosis) 04/2021 - 12/2014
2	Rheumatic Fever (Acute Articular Rheumatism) 01/2017 - 10/2016
2	Heart Arrest (Cardiac Arrest) 01/2016 - 07/2013
2	ST Elevation Myocardial Infarction 06/2015 - 07/2013
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2013 - 10/2008
1	COVID-19 01/2022
1	Systolic Heart Failure 12/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Pulmonary Hypertension 01/2017
1	Bicuspid Aortic Valve Disease 10/2016
1	Ventricular Remodeling 01/2016
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Embolism (Embolus) 01/2016
1	Stroke (Strokes) 01/2016
1	Non-ST Elevated Myocardial Infarction 06/2015
1	Pulmonary Embolism 04/2015
1	Venous Thromboembolism 04/2015
1	Prolapse 01/2015
1	Syncope (Fainting) 09/2014
1	Left Ventricular Dysfunction 05/2014
1	Bundle-Branch Block (Fascicular Block) 05/2014
1	Sudden Death 07/2013
1	Cardiac Arrhythmias (Arrythmia) 07/2013
1	Ventricular Tachycardia 07/2013
1	Diabetes Mellitus 12/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2012
1	Hypertension (High Blood Pressure) 04/2012
1	Cardiogenic Shock 04/2012
1	Pheochromocytoma 04/2012
1	Neoplasms (Cancer) 04/2012
1	Disease Susceptibility (Diathesis) 10/2010
1	Patent Foramen Ovale 06/2007
1	Dyspnea (Shortness of Breath) 11/2002

Drug/Important Bio-Agent (IBA)

9	benfluorex (S 780)IBA 01/2017 - 12/2012
5	Pharmaceutical PreparationsIBA 01/2017 - 06/2013
2	TicagrelorIBA 01/2022 - 04/2019
2	SodiumIBA 07/2015 - 09/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 10/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2014 - 11/2002
2	von Willebrand FactorIBA 10/2010 - 10/2008
2	CalciumIBA 05/2006 - 05/2006
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2006 - 05/2006
1	remdesivirIBA 01/2022
1	FenfluramineIBA 04/2021
1	Purinergic P2Y Receptor AntagonistsIBA 04/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019
1	alirocumabIBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2016
1	ThienopyridinesIBA 01/2016
1	CreatinineIBA 07/2015
1	Enoxaparin (Lovenox)FDA LinkGeneric 06/2015
1	AnticoagulantsIBA 06/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2015
1	Fondaparinux (Arixtra)FDA Link 06/2015
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2015
1	PotassiumIBA 09/2014
1	pro-brain natriuretic peptide (1-76)IBA 02/2014
1	GadoliniumIBA 10/2013
1	AldosteroneIBA 07/2013
1	Anti-Arrhythmia AgentsIBA 07/2013
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 07/2013
1	ORALIT (ORS)IBA 07/2013
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2013
1	Serotonin (5 Hydroxytryptamine)IBA 06/2013
1	CatecholaminesIBA 04/2012
1	Thrombin FDA Link 12/2010
1	OsteopontinIBA 12/2010
1	Thromboplastin (Tissue Factor)IBA 12/2010
1	AT 112IBA 10/2010
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 08/2010
1	serpentine (alkaloid)IBA 06/2007
1	Bisoprolol (Concor)FDA LinkGeneric 01/2007
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2006

Therapy/Procedure

7	Cardiac Resynchronization Therapy 01/2021 - 05/2014
5	Therapeutics 01/2015 - 05/2006
2	Percutaneous Coronary Intervention 01/2016 - 07/2013
1	Secondary Prevention 01/2018
1	Radiotherapy 10/2016
1	Lasers (Laser) 01/2016
1	Vena Cava Filters (Inferior Vena Cava Filter) 04/2015
1	Resuscitation 07/2013
1	Length of Stay 10/2012
1	Extracorporeal Membrane Oxygenation 04/2012
1	Transplantation 10/2010
1	Heart Transplantation (Grafting, Heart) 10/2010
1	Heart-Assist Devices 10/2010
1	Radiofrequency Ablation 05/2005